Immediate Impact
1 by Nobel laureates 2 from Science/Nature 56 standout
Citing Papers
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones
2023 Standout
Works of Roberta Maltoni being referenced
Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence
2018
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Roberta Maltoni | 690 | 358 | 287 | 328 | 82 | 1.2k | |
| Miguel Ángel Seguí | 863 | 431 | 219 | 261 | 84 | 1.3k | |
| Ji‐Yeon Kim | 504 | 403 | 278 | 398 | 108 | 1.3k | |
| Takeo Fujii | 493 | 321 | 256 | 291 | 72 | 1.2k | |
| Elisa Agostinetto | 956 | 455 | 416 | 240 | 84 | 1.4k | |
| José Luís Passos‐Coelho | 897 | 282 | 284 | 272 | 46 | 1.3k | |
| E.J. Shpall | 558 | 207 | 216 | 247 | 47 | 1.4k | |
| Hani M. Babiker | 649 | 268 | 360 | 348 | 147 | 1.4k | |
| Mireia Margelí Vila | 759 | 465 | 396 | 427 | 94 | 1.3k | |
| Patrizia Serra | 574 | 237 | 252 | 268 | 50 | 968 | |
| Davide Lombardi | 593 | 206 | 301 | 200 | 57 | 968 |
All Works
Login with ORCID to disown or claim papers
Loading papers...